The mission of the Office of Health Promotion Research is to further knowledge and understanding of health promotion and disease prevention through the development of theory-based rigorously controlled research in health education and health promotion.

Our current research is primarily focused on the promotion and surveillance of effective breast cancer screening through the Vermont Breast Cancer Surveillance System. We are one of six core sites of the national Breast Cancer Surveillance Consortium, as well as the PROSPR Research Center funded by the National Cancer Institute to conduct research to improve the cancer screening process.

Our earlier research focused on tobacco control through smoking prevention and smoking cessation, AIDS prevention, diabetes prevention, and reducing alcohol use by youth. These research projects grew out of earlier ones which we have carried out since the early 1980s by emeriti faculty members Roger H. Secker-Walker M.D., John K. Worden, Ph.D., Brian S. Flynn, Sc.D., Berta Geller, Ed.D., and Laura J. Solomon, Ph.D.

UVM COM PostDoc award Hart
digital mammography_186x140
Larner COM and UVM aerial view
  • UVM Announces 2018-19 SPARK-VT Grant Recipients
    September 14, 2018 by Jennifer Nachbur
    Three innovative projects spanning the fields of regenerative medicine, electrophysiology, and infectious diseases were selected to receive SPARK-VT research funding following a June 22 proposal presentation meeting at which University of Vermont faculty applicants pitched ideas to a panel of consultants from the biomedical and biotech arena. The awardees include UVM Larner College of Medicine Department of Medicine faculty members Daniel Weiss, M.D., Ph.D., Jason Botten, Ph.D., and Peter Spector, M.D.
  • Setting the Stage for Active Learning: Q&A with Jesse Moore, M.D.
    September 7, 2018 by Erin Post
  • Obesity Neural Systems Expert Grill Presents Stetson Lecture
    September 6, 2018 by Jennifer Nachbur
    Harvey J. Grill, Ph.D., presented the Annual Stetson Lecture in Technological Advances in Medicine on Friday, September 14, 2018 in the UVM Davis Center’s Silver Maple Ballroom. Grill, a professor of behavioral neuroscience at the University of Pennsylvania and director of the Obesity Unit at the Institute of Diabetes, Obesity and Metabolism, discussed “Treating the Hyperphagia Driving Obesity: Neural Mechanisms of Feeding Inhibition.”
  • Jensen Co-Authors Global Criteria for Diagnosing Malnutrition
    September 5, 2018 by Jennifer Nachbur
    Although malnutrition is a serious concern associated with adverse outcomes and cost, no single existing approach to malnutrition diagnosis has achieved broad global acceptance. Now, thanks to more than two years’ work by members of the Global Leadership Initiative on Malnutrition (GLIM) working group, a consensus report, which outlines five criteria for malnutrition, has just been published in the latest issue of both the Journal of Parenteral and Enteral Nutrition and Clinical Nutrition.
  • Seeing home through the eyes of a volunteer
    September 4, 2018 by Michelle Bookless
    This summer, University of Vermont Larner College of Medicine medical student Hanaa Shihadeh '21 had a chance to see her native country of Jordan through a different set of eyes - those of a Syrian American Medical Society (SAMS) volunteer.
  • Treating the Hyperphagia Driving Obesity: Neural Mechanisms of Feeding Inhibition, Sept 14, 2018
    August 30, 2018 by Jennifer Smith
    Harvey J. Grill PhD, Professor of Behavioral Neuroscience, University of Pennsylvania; Director of the Obesity Unit, Institute of Diabetes, Obesity and Metabolism. A leader in the field of obesity and anorexia, Dr. Grill's research focuses on defining the neural circuits, neurochemical systems, and intracellular signaling pathways that contribute to the control of food intake, food reward, and associative control on feeding. Livestream available.
  • NIH Names Langevin Director of National Center for Complementary & Integrative Health
    August 29, 2018 by Jennifer Nachbur
    Helene Langevin, M.D., C.M., a visiting professor of neurological sciences at the Larner College of Medicine at the University of Vermont and director of the Osher Center for Integrative Medicine at Brigham and Women's Hospital and Harvard Medical School, has been named director of the National Center for Complementary and Integrative Health.
  • Shukla's Study on Exosomes role in the development of Mesothelioma Featured by the Department of Defense
    August 22, 2018 by Madi Wood
    The United States Department of Defense published an online article about Arti Shukla's, Ph.D., UVM associate professor of pathology and laboratory medicine, research study regarding the role of exosomes in the development of mesothelioma.
  • Covington Speaks with Boston Globe About Opioid Prescribing-Related Studies
    August 22, 2018 by Madi Wood
    UVM Assistant Professor of Anesthesiology Melissa Covington, M.D. was interviewed by the Boston Globe to discuss the results of recent studies relating to opioid prescribing practices.
  • Conference: Women's Health & Cancer, October 5, 2018
    August 22, 2018 by Jennifer Smith
    The University of Vermont Cancer Center will present the 21st Annual Conference as a day of education for patients, survivors, health care providers, family members, and all others interested in women's health.
  • LaMantia Invested as Inaugural Holly and Bob Miller Chair in Memory and Aging
    August 21, 2018 by Jennifer Nachbur
    More than 150 people gathered for a formal investiture ceremony honoring the University of Vermont’s newest endowed faculty members and recognizing the donors who made the positions possible on August 21, 2018 at the UVM Alumni House. Michael LaMantia, M.D., M.P.H., was invested as the inaugural Holly and Bob Miller Chair in Memory and Aging and Rosemary Dale, Ed.D., A.P.R.N., was invested as the first Holly and Bob Miller Professor in Nursing Leadership.
  • UVM Vaccine Testing Center Highlighted for Participation in Zika Vaccine Trial
    August 16, 2018 by Madi Wood
    On Thursday, August 16, the National Institute of Allergy and Infectious Diseases (NIAID) announced that vaccinations have begun in a first-in-human trial of an experimental live, attenuated Zika virus vaccine.
  • Teaching Academy Announces 16 New Members
    August 20, 2018 by Jennifer Nachbur
    Kathryn Huggett, Ph.D., director of the Teaching Academy at the Larner College of Medicine at the University of Vermont, has announced the names of 16 new members of the Teaching Academy.
  • What’s Up (Future) Doc? College Welcomes Class of 2022 to Campus
    August 16, 2018 by Jennifer Nachbur
  • Vaccine Testing Center a Site for New NIH Live, Attenuated Zika Vaccine Trial
    August 16, 2018 by Jennifer Nachbur
    Vaccinations have begun in a first-in-human trial of an experimental live, attenuated Zika virus vaccine developed by scientists at the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health. The trial will enroll a total of 28 healthy, non-pregnant adults ages 18 to 50 at the Johns Hopkins Bloomberg School of Public Health Center for Immunization Research in Baltimore, Md., and at the Vaccine Testing Center at the Larner College of Medicine at the University of Vermont in Burlington.
  • Leopold Study on Phantom Odors Gains National Coverage
    August 16, 2018 by Madi Wood
    A study co-authored by Donald Leopold, M.D., UVM clinical professor of surgery, is co-focuses on phantom odors in aging Americans. According to the study, 1 in 15 Americans over the age of 40 experience smelling unpleasant scents with no apparent source.
  • Ahern Receives St. Baldrick's Foundation Grant to Study Phthalates & Cancer
    August 7, 2018 by Sarah Keblin
    UVM Assistant Professor of Surgery Thomas Ahern, Ph.D., is the recipient of one of 76 St. Baldrick's Foundation grants totaling more than $19.1 million to support studying innovative treatment options in the pediatric cancer space.
  • Putting the Active in Learning – Med Students Bring First-hand Insight to Curriculum
    August 7, 2018 by Michelle Bookless
    As the Larner College of Medicine at the University of Vermont works toward a curriculum that is 100 percent lecture-free by 2019, faculty aren’t the only ones helping move the transition forward; medical students are playing a critical role in creating active learning curriculum as well.
  • Center on Aging Hosts Beers Fund in Geriatrics Lecture on “Caring for the Caregiver”
    July 31, 2018 by Jennifer Nachbur
    The University of Vermont Center on Aging and UVM Geriatric Medicine program will host a presentation, titled “Caring for Caregivers and Transitions from Hospital to Home,” by international experts Horst Vollmar, M.D., M.P.H., and Mary Austrom, Ph.D., on August 3, 2018.
  • Parsons Leads American Thoracic Society, Named ATS Fellow with 3 UVM Colleagues
    July 26, 2018 by Jennifer Nachbur
    At the American Thoracic Society 2018 International Congress, held in May 2018, UVM E.L. Amidon Chair of Medicine Polly Parsons, M.D., was installed as president, and she and Larner College of Medicine colleagues Jason Bates, Ph.D., Sc.D., Anne Dixon, M.A., B.M., B.Ch., and Renee Stapleton, M.D., Ph.D., were inducted as the inaugural class of ATS Fellows.